Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery.

IF 8.1 Q1 ENGINEERING, BIOMEDICAL Biomaterials research Pub Date : 2023-11-29 DOI:10.1186/s40824-023-00456-w
Hochung Jang, Hyosuk Kim, Eun Hye Kim, Geonhee Han, Yeongji Jang, Yelee Kim, Jong Won Lee, Sang Chul Shin, Eunice EunKyeong Kim, Sun Hwa Kim, Yoosoo Yang
{"title":"Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery.","authors":"Hochung Jang, Hyosuk Kim, Eun Hye Kim, Geonhee Han, Yeongji Jang, Yelee Kim, Jong Won Lee, Sang Chul Shin, Eunice EunKyeong Kim, Sun Hwa Kim, Yoosoo Yang","doi":"10.1186/s40824-023-00456-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recently, increased attention has been given on exosomes as ideal nanocarriers of drugs owing to their intrinsic properties that facilitate the transport of biomolecular cargos. However, large-scale exosome production remains a major challenge in the clinical application of exosome-based drug delivery systems. Considering its biocompatibility and stability, bovine milk is a suitable natural source for large-scale and stable exosome production. Because the active-targeting ability of drug carriers is essential to maximize therapeutic efficacy and minimize side effects, precise membrane functionalization strategies are required to enable tissue-specific delivery of milk exosomes with difficulty in post-isolation modification.</p><p><strong>Methods: </strong>In this study, the membrane functionalization of a milk exosome platform modified using a simple post-insertion method was examined comprehensively. Exosomes were engineered from bovine milk (mExo) with surface-tunable modifications for the delivery of tumor-targeting doxorubicin (Dox). The surface modification of mExo was achieved through the hydrophobic insertion of folate (FA)-conjugated lipids.</p><p><strong>Results: </strong>We have confirmed the stable integration of functionalized PE-lipid chains into the mExo membrane through an optimized post-insertion technique, thereby effectively enhancing the surface functionality of mExo. Indeed, the results revealed that FA-modified mExo (mExo-FA) improved cellular uptake in cancer cells via FA receptor (FR)-mediated endocytosis. The designed mExo-FA selectively delivered Dox to FR-positive tumor cells and triggered notable tumor cell death, as confirmed by in vitro and in vivo analyses.</p><p><strong>Conclusions: </strong>This simple and easy method for post-isolation modification of the exosomal surface may be used to develop milk-exosome-based drug delivery systems.</p>","PeriodicalId":93902,"journal":{"name":"Biomaterials research","volume":"27 1","pages":"124"},"PeriodicalIF":8.1000,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688116/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomaterials research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40824-023-00456-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Recently, increased attention has been given on exosomes as ideal nanocarriers of drugs owing to their intrinsic properties that facilitate the transport of biomolecular cargos. However, large-scale exosome production remains a major challenge in the clinical application of exosome-based drug delivery systems. Considering its biocompatibility and stability, bovine milk is a suitable natural source for large-scale and stable exosome production. Because the active-targeting ability of drug carriers is essential to maximize therapeutic efficacy and minimize side effects, precise membrane functionalization strategies are required to enable tissue-specific delivery of milk exosomes with difficulty in post-isolation modification.

Methods: In this study, the membrane functionalization of a milk exosome platform modified using a simple post-insertion method was examined comprehensively. Exosomes were engineered from bovine milk (mExo) with surface-tunable modifications for the delivery of tumor-targeting doxorubicin (Dox). The surface modification of mExo was achieved through the hydrophobic insertion of folate (FA)-conjugated lipids.

Results: We have confirmed the stable integration of functionalized PE-lipid chains into the mExo membrane through an optimized post-insertion technique, thereby effectively enhancing the surface functionality of mExo. Indeed, the results revealed that FA-modified mExo (mExo-FA) improved cellular uptake in cancer cells via FA receptor (FR)-mediated endocytosis. The designed mExo-FA selectively delivered Dox to FR-positive tumor cells and triggered notable tumor cell death, as confirmed by in vitro and in vivo analyses.

Conclusions: This simple and easy method for post-isolation modification of the exosomal surface may be used to develop milk-exosome-based drug delivery systems.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
插入后技术在乳外泌体中引入靶向部分用于靶向药物递送。
背景:近年来,外泌体作为理想的药物纳米载体越来越受到关注,因为它们具有促进生物分子货物运输的内在特性。然而,大规模的外泌体生产仍然是基于外泌体的药物输送系统临床应用的主要挑战。考虑到其生物相容性和稳定性,牛奶是大规模和稳定生产外泌体的合适天然来源。由于药物载体的活性靶向能力对于最大化治疗效果和最小化副作用至关重要,因此需要精确的膜功能化策略来实现分离后修饰困难的乳外泌体的组织特异性递送。方法:采用简单的后插入法修饰乳外泌体平台,对其膜功能化进行了全面的研究。外泌体由牛乳(mExo)工程化,表面可调修饰,用于递送靶向肿瘤的阿霉素(Dox)。通过疏水插入叶酸(FA)共轭脂质实现了mExo的表面修饰。结果:通过优化后插入技术,我们证实了功能化pe -脂链稳定整合到mExo膜中,从而有效地增强了mExo的表面功能。事实上,结果显示,FA修饰的mExo (mExo-FA)通过FA受体(FR)介导的内吞作用改善了癌细胞的细胞摄取。设计的mExo-FA选择性地将Dox传递给fr阳性肿瘤细胞,并引发显著的肿瘤细胞死亡,这一点得到了体外和体内分析的证实。结论:这种分离后修饰外泌体表面的方法简便易行,可用于开发基于乳外泌体的给药系统。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Harnessing the Intradermal Delivery of Hair Follicle Dermal Papilla Cell Spheroids for Hair Follicle Regeneration in Nude Mice. Human Hair Follicle Mesenchymal Stem Cell-Derived Exosomes Attenuate UVB-Induced Photoaging via the miR-125b-5p/TGF-β1/Smad Axis. A Novel Cell-Penetrating Peptide-Vascular Endothelial Growth Factor Small Interfering Ribonucleic Acid Complex That Mediates the Inhibition of Angiogenesis by Human Umbilical Vein Endothelial Cells and in an Ex Vivo Mouse Aorta Ring Model. Functionalized Periosteum-Derived Microsphere-Hydrogel with Sequential Release of E7 Short Peptide/miR217 for Large Bone Defect Repairing. A Magnetic-Responsive Biomimetic Nanosystem Coated with Glioma Stem Cell Membranes Effectively Targets and Eliminates Malignant Gliomas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1